On a consolidated basis, Bharti Airtel's net profit fell 16.50% to Rs 560.70 crore on 12.93% decline in net sales to Rs 20318.60 crore in Q3 December 2017 over Q3 December 2016. The result was announced after market hours yesterday, 18 January 2018.

HDFC Bank, IDFC Bank, ITC, Kotak Mahindra Bank and Wipro will declare October-December 2017 results on Friday, 19 January 2018.

Tech Mahindra said that it will acquire 17.5% stake in US-based Altiostar Networks for $15 million. Altiostar is a telecom software development company, having presence in 6 countries in Europe, APAC and Latam regions. The announcement was made after market hours yesterday, 18 January 2018.

Healthcare Global Enterprises will be watched. The Reserve Bank of India (RBI) yesterday, 18 January 2018, notified that the foreign investment limit for investment by Foreign Portfolios Investors (FPIs) in Healthcare Global Enterprises has increased from 24% to 100% of its paid up capital. HealthCare Global Enterprises has passed necessary resolutions of its board of directors and general body.

Further, owing to the above increase in the investment limit, it is notified that the aggregate shareholding by FPIs in HealthCare Global Enterprises has gone below the prescribed FPIs investment limit for the company. Hence, the restrictions placed on the purchase of shares of the above company by FPIs are withdrawn with immediate effect.

Alembic said that its board will consider the proposal for buyback of fully paid-up equity shares of the company on 23 January 2018. The announcement was made after market hours yesterday, 18 January 2018.

Biocon and Sandoz, a Novartis division and a global leader in biosimilars, announced a global partnership to develop, manufacture and commercialize multiple biosimilars in immunology and oncology for patients worldwide. Under the terms of the agreement, both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products and will have a cost and profit share arrangement globally. Worldwide commercialization responsibilities will be divided and each company's strengths will be leveraged within specific geographies. Sandoz will lead commercialization in North America and the European Union (EU) while Biocon will lead commercialization in Rest of the World. The announcement was made after market hours yesterday, 18 January 2018.

Savita Oil Technologies said that its board will consider the proposal for buyback of fully paid-up equity shares of the company on 23 January 2018. The announcement was made after market hours yesterday, 18 January 2018.

Torrent Pharmaceuticals announced the acquisition of Bio-Pharm, Inc. (BPI) a generic pharmaceuticals and OTC company, based in Levittown Pennsylvania, USA. Established in 1992, BPI has a proven track record in the research & development and manufacturing of oral solutions, suspensions and suppositories. This acquisition is an important step for increasing Torrent's presence in the United States. This acquisition is consistent with the company's strategy of dosage form diversification and provides it with new capabilities including manufacturing and research and development (R&D) presence in the USA. The announcement was made after market hours yesterday, 18 January 2018.

Powered by Capital Market - Live News